HOME >> MEDICINE >> NEWS
Brief exposure to Mandarin can help American infants learn Chinese

tested to see if they could distinguish between two Mandarin sounds that do not occur in English. Americans often hear both sounds as "chee" or "she." These sounds are difficult for adult Americans to distinguish between but present no problem for native Mandarin speakers.

In the first study, normally developing 9-month-olds were exposed to Mandarin during a dozen 25-minutes sessions spaced out over four weeks. During these sessions, native Mandarin speakers read from children's books and played with toys while speaking Mandarin. Four different speakers, two men and two women, conducted the sessions, so the babies were exposed to a variety of speaking styles. A control group of infants was exposed to the same procedure in English.

Both groups then were tested for their ability to distinguish between the two Mandarin sounds using a head-turn conditioning procedure that is frequently used in tests of infant speech perception. The infants exposed to Mandarin were significantly better at distinguishing the two target sounds than were infants who only heard English. In fact, the performance of the American infants exposed to Mandarin for the first time between 9 and 10 months was statistically equivalent to infants in Taiwan who had listened to Mandarin for 10 months, according to Kuhl. The results show that the decline in foreign-language speech perception can be reversed with short-term exposure, she said.

In addition, the phonetic learning of Mandarin appears to be long lasting. The American infants were tested from two to 12 days after their last exposure to Mandarin and the researchers found there were no significant differences in their ability to discriminate between the sounds.

"In previous learning studies babies were exposed to artificial languages for a few minutes and no one expected that kind of exposure to produce long-lasting effects," said Kuhl "We predicted that learning in this natural situation would produce a longer lasting eff
'"/>

Contact: Joel Schwarz
joels@u.washington.edu
206-543-2580
University of Washington
17-Feb-2003


Page: 1 2 3 4

Related medicine news :

1. Institute of Medicine advisory: Jan. 12 Briefing on Complementary and Alternative Medicine
2. LA BioMed Medical/Research Briefs December 2004
3. National Academies Advisory: April 1 Public Briefing on Safety of Dietary Supplements
4. Brief mail- and computer-generated interventions work best for problem drinking among young people
5. Academy launches eBriefings Web site to help scientists
6. Brief telephonic questionnaire detects early signs of dementia
7. Brief exercise improves mental performance in people with chronic lung disease
8. APA Annual Meeting Media Briefings Schedule
9. Schedule Of APA Media Briefings
10. Experts To Discuss Findings From New Lewin Group Study In Conference Call Briefing
11. Multi-center study shows direct link between residential radon exposure and lung cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Brief exposure Mandarin can help American infants learn Chinese

(Date:4/14/2014)... been made in chemotherapy over the past decade, but ... continues to be a major challenge. , Nanotechnology ... the use of nanocarriers, or capsules, that can transport ... body. , The catch? These carriers are tiny, and ...
(Date:4/14/2014)... the 20th century, is currently losing a lot of ... at the University of South Carolina have just reported ... against so-called "superbugs." , Bacteria have been chipping away ... since their first wide-scale use as antibiotics in the ...
(Date:4/14/2014)... web information on colorectal cancer is too difficult for ... appropriate risks to and concerns of patients, a study ... a review of a dozen popular websites, most of ... were written beyond the recommended sixth-grade reading level, while ...
(Date:4/14/2014)... Inc., announced today a publication demonstrating that the company,s ... cells exposed to plasma samples of patients with a ... "TNT003, an inhibitor of the serine protease C1s, prevents ... was published on-line in the journal Blood ...
(Date:4/14/2014)... Child Development Institute have released their new study of ... success in kindergarten. According to FPG,s report, students enrolled ... of learning. , "Children are progressing at an ... than expected for normal developmental growth," said senior scientist ...
Breaking Medicine News(10 mins):Health News:Nano shake-up 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Study gives high marks to NC Pre-K program 2
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... application concerning composition of matter, biological targets, mechanism of ... death.  This patent application describes a ... molecules (VSRNAs) which interfere with the basic homeostatic cellular ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
Cached News: